Skip to content

GalaFORM 3D 100043-13

by Tepha, Inc.

GalaFORM 3D 100043-13 (FR3D13), an extra-gynaecological surgical mesh (FDA Class II; FDA product code OOD, Surgical Film) made by Tepha, Inc., was cleared under FDA 510(k) K162922 on 23 Feb 2017 and listed in FDA GUDID on 1 May 2017 (UDI-DI 00855920006348); the registry lists it as not in commercial distribution (GUDID) as of 22 Oct 2026.

Active United States. Also listed in GUDID (US), not in commercial distribution.

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

510(k) K162922

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00855920006348 UDI-DI Date1 May 2017ListedStatusListed GUDID: not in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK162922 Date23 Feb 2017DecidedStatusActive

Official records

From the FDA record

Device description
GalaFORM 3D scaffold is a bioresorbable surgical mesh manufactured from poly-4-hydroxybutyrate (P4HB). P4HB is produced from a naturally occurring monomer and is processed into monofilament fibers and knitted into a surgical scaffold. The scaffold has a 3D curvature supported with a P4HB rim designed to promote better conformance with a patient's anatomy in locations in which a flat design does not easily conform. P4HB bioresorbs through a process of hydrolysis and hydrolytic enzymatic digestion. It has been developed to optimize resorption rate and prolong strength retention in order to provide support throughout the expected period of healing. Although the scaffold loses strength with time, its porous construction was designed to allow native tissue ingrowth and gradual transfer of load from the scaffold to the tissue. Pre-clinical implantation studies indicate that GalaFORM 3D scaffold retains approximately 70% of its strength at 12 weeks. Bioresorption of the scaffold material will be essentially complete within 18-24 months.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied sterile; sterilise before use (Ethylene Oxide)

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K162922 decided 23 Feb 2017 Active
  • FDA GUDID UDI-DI 00855920006348 listed 1 May 2017 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K162922
  2. Listed FDA GUDID 00855920006348

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
GalaFORM 3D
Generic name
Extra-gynaecological surgical mesh, synthetic polymer, bioabsorbable
Model / Ref / Catalog
100043-13, FR3D13
Primary DI / UDI-DI
00855920006348
510(k) Number
FDA product code
OOD
GMDN term
Extra-gynaecological surgical mesh, synthetic polymer, bioabsorbable
Device class
Class II
Regulation number
878.3300
GUDID distribution status
Not in Commercial Distribution
Sterilisation method
Ethylene Oxide
Size
Outer Diameter — 7.6 Centimeter

Similar devices

Other devices filed under FDA product code OOD (Surgical Film).

Other devices from Tepha, Inc.

See all devices from Tepha, Inc. →

Properties

  • Supplied sterile
  • Sterilise before use
  • Single use
  • Implantable
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (8, all answered No)